Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

COVID-19: Daily Top 10 Papers

  Stem Cell Research

  Free Subscription

Articles published in Cancer

Retrieve available abstracts of 32 articles:
HTML format

Single Articles

    March 2021
  1. NAGLER A, Labopin M, Koc Y, Angelucci E, et al
    Outcome of T-cell-replete haploidentical stem cell transplantation improves with time in adults with acute lymphoblastic leukemia: A study from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation.
    Cancer. 2021 Mar 19. doi: 10.1002/cncr.33522.
    PubMed     Abstract available

    February 2021
  2. AMONOO HL, Johnson PC, Dhawale TM, Traeger L, et al
    Sharing and caring: The impact of social support on quality of life and health outcomes in hematopoietic stem cell transplantation.
    Cancer. 2021 Feb 17. doi: 10.1002/cncr.33455.
    PubMed     Abstract available

    October 2020
  3. BATTIPAGLIA G, Labopin M, Hamladji RM, Blaise D, et al
    Post-transplantation cyclophosphamide versus antithymocyte globulin in patients with acute myeloid leukemia undergoing allogeneic stem cell transplantation from HLA-identical sibling donors: A retrospective analysis from the Acute Leukemia Working Par
    Cancer. 2020 Oct 29. doi: 10.1002/cncr.33255.
    PubMed     Abstract available

  4. ZERR DM, Milstone AM, Dvorak CC, Adler AL, et al
    Chlorhexidine gluconate bathing in children with cancer or those undergoing hematopoietic stem cell transplantation: A double-blinded randomized controlled trial from the Children's Oncology Group.
    Cancer. 2020 Oct 20. doi: 10.1002/cncr.33271.
    PubMed     Abstract available

  5. JACOBS JM, Nelson AM, Traeger L, Waldman L, et al
    Enhanced coping and self-efficacy in caregivers of stem cell transplant recipients: Identifying mechanisms of a multimodal psychosocial intervention.
    Cancer. 2020 Oct 7. doi: 10.1002/cncr.33191.
    PubMed     Abstract available

    May 2020
  6. ARORA M, Chen Y, Hageman L, Wu J, et al
    Morbidity burden in survivors of multiple myeloma who underwent autologous transplantation: A Bone Marrow Transplantation Survivor Study.
    Cancer. 2020 May 15. doi: 10.1002/cncr.32941.
    PubMed     Abstract available

    March 2020
  7. CUSATIS RN, Tecca HR, D'Souza A, Shaw BE, et al
    Prevalence of decisional regret among patients who underwent allogeneic hematopoietic stem cell transplantation and associations with quality of life and clinical outcomes.
    Cancer. 2020 Mar 10. doi: 10.1002/cncr.32808.
    PubMed     Abstract available

    February 2020
  8. MURDAUGH DL, Bosworth A, Patel SK, Sharafeldin N, et al
    Self-endorsed cognitive problems versus objectively assessed cognitive impairment in blood or bone marrow transplantation recipients: A longitudinal study.
    Cancer. 2020 Feb 25. doi: 10.1002/cncr.32773.
    PubMed     Abstract available

  9. BAIR SM, Brandstadter JD, Ayers EC, Stadtmauer EA, et al
    Hematopoietic stem cell transplantation for blood cancers in the era of precision medicine and immunotherapy.
    Cancer. 2020 Feb 19. doi: 10.1002/cncr.32659.
    PubMed     Abstract available

    January 2020
  10. EL-JAWAHRI A, Jacobs JM, Nelson AM, Traeger L, et al
    Multimodal psychosocial intervention for family caregivers of patients undergoing hematopoietic stem cell transplantation: A randomized clinical trial.
    Cancer. 2020 Jan 3. doi: 10.1002/cncr.32680.
    PubMed     Abstract available

    December 2019
  11. LI Y, Zang H, Qian G, Owonikoko TK, et al
    ERK inhibition effectively overcomes acquired resistance of epidermal growth factor receptor-mutant non-small-cell lung cancer cells to osimertinib.
    Cancer. 2019 Dec 10. doi: 10.1002/cncr.32655.
    PubMed     Abstract available

    November 2019
  12. GORIN NC, Labopin M, Blaise D, de Groot M, et al
    Stem cell transplantation from a haploidentical donor versus a genoidentical sister for adult male patients with acute myelogenous leukemia in first remission: A retrospective study from the acute leukemia working party of the European Society for Blo
    Cancer. 2019 Nov 27. doi: 10.1002/cncr.32629.
    PubMed     Abstract available

  13. KALRA M, Adra N, Hanna N, Abonour R, et al
    High-dose chemotherapy plus peripheral blood stem cell transplantation for patients with relapsed germ cell tumors and active brain metastases.
    Cancer. 2019 Nov 19. doi: 10.1002/cncr.32628.
    PubMed     Abstract available

    August 2019
  14. EPPERLA N, Hamadani M, Reljic T, Kharfan-Dabaja MA, et al
    Upfront autologous hematopoietic stem cell transplantation consolidation for patients with aggressive B-cell lymphomas in first remission in the rituximab era: A systematic review and meta-analysis.
    Cancer. 2019 Aug 23. doi: 10.1002/cncr.32464.
    PubMed     Abstract available

    July 2019
  15. CHEN Y, Zhang R, Wang L, Correa AM, et al
    Tumor characteristics associated with engraftment of patient-derived non-small cell lung cancer xenografts in immunocompromised mice.
    Cancer. 2019 Jul 9. doi: 10.1002/cncr.32366.
    PubMed     Abstract available

    June 2019
  16. SHOUVAL R, Labopin M, Gorin NC, Bomze D, et al
    Individualized prediction of leukemia-free survival after autologous stem cell transplantation in acute myeloid leukemia.
    Cancer. 2019 Jun 21. doi: 10.1002/cncr.32344.
    PubMed     Abstract available

    April 2019
  17. MINA R, Lonial S
    Is there still a role for stem cell transplantation in multiple myeloma?
    Cancer. 2019 Apr 15. doi: 10.1002/cncr.32060.
    PubMed     Abstract available

    January 2019
  18. PARK SI, Horwitz SM, Foss FM, Pinter-Brown LC, et al
    The role of autologous stem cell transplantation in patients with nodal peripheral T-cell lymphomas in first complete remission: Report from COMPLETE, a prospective, multicenter cohort study.
    Cancer. 2019 Jan 29. doi: 10.1002/cncr.31861.
    PubMed     Abstract available

  19. SANTORO N, Labopin M, Ciceri F, Van Lint MT, et al
    Impact of conditioning intensity on outcomes of haploidentical stem cell transplantation for patients with acute myeloid leukemia over 45 years of age.
    Cancer. 2019 Jan 8. doi: 10.1002/cncr.31941.
    PubMed     Abstract available

    October 2018
  20. HARADA K, Pool Pizzi M, Baba H, Shanbhag ND, et al
    Cancer stem cells in esophageal cancer and response to therapy.
    Cancer. 2018 Oct 25. doi: 10.1002/cncr.31697.

  21. BAZARBACHI A, Boumendil A, Finel H, Mohty M, et al
    Brentuximab vedotin for recurrent Hodgkin lymphoma after allogeneic hematopoietic stem cell transplantation: A report from the EBMT Lymphoma Working Party.
    Cancer. 2018 Oct 23. doi: 10.1002/cncr.31755.
    PubMed     Abstract available

    June 2018
  22. SORIGUE M, Sancho JM
    The persistent uncertainty of when to recommend allogeneic stem cell transplantation in follicular lymphoma.
    Cancer. 2018 Jun 7. doi: 10.1002/cncr.31565.

  23. SUREDA A, Montoto S, Dreger P, Hamadani M, et al
    Reply to The persistent uncertainty of when to recommend allogeneic stem cell transplantation in follicular lymphoma.
    Cancer. 2018 Jun 7. doi: 10.1002/cncr.31564.

    March 2018
  24. CZERW T, Labopin M, Giebel S, Socie G, et al
    Anti-thymocyte globulin improves survival free from relapse and graft-versus-host disease after allogeneic peripheral blood stem cell transplantation in patients with Philadelphia-negative acute lymphoblastic leukemia: An analysis by the Acute Leukemi
    Cancer. 2018 Mar 30. doi: 10.1002/cncr.31354.
    PubMed     Abstract available

  25. EL-JAWAHRI A, Fishman SR, Vanderklish J, Dizon DS, et al
    Pilot study of a multimodal intervention to enhance sexual function in survivors of hematopoietic stem cell transplantation.
    Cancer. 2018 Mar 14. doi: 10.1002/cncr.31333.
    PubMed     Abstract available

  26. XUAN L, Wang Y, Huang F, Jiang E, et al
    Effect of sorafenib on the outcomes of patients with FLT3-ITD acute myeloid leukemia undergoing allogeneic hematopoietic stem cell transplantation.
    Cancer. 2018 Mar 6. doi: 10.1002/cncr.31295.
    PubMed     Abstract available

    February 2018
  27. SESTILI S, Labopin M, Ruggeri A, Velardi A, et al
    T-cell-depleted haploidentical stem cell transplantation results improve with time in adults with acute leukemia: A study from the Acute Leukemia Working Party of the European Society of Blood and Marrow Transplantation (EBMT).
    Cancer. 2018 Feb 22. doi: 10.1002/cncr.31310.
    PubMed     Abstract available

  28. Erratum: Chang Y-J, Wang Y, Mo X-D, et al. Optimal dose of rabbit thymoglobulin in conditioning regimens for unmanipulated, haploidentical, hematopoietic stem cell transplantation: Long-term outcomes of a prospective randomized trial. Cancer. 2017;123
    Cancer. 2018;124:868.

  29. SUREDA A, Zhang MJ, Dreger P, Carreras J, et al
    Allogeneic hematopoietic stem cell transplantation for relapsed follicular lymphoma: A combined analysis on behalf of the Lymphoma Working Party of the EBMT and the Lymphoma Committee of the CIBMTR.
    Cancer. 2018 Feb 9. doi: 10.1002/cncr.31264.
    PubMed     Abstract available

    January 2018
  30. RUGGERI A, Labopin M, Bacigalupo A, Gulbas Z, et al
    Bone marrow versus mobilized peripheral blood stem cells in haploidentical transplants using posttransplantation cyclophosphamide.
    Cancer. 2018 Jan 23. doi: 10.1002/cncr.31228.
    PubMed     Abstract available

    November 2017
  31. RUUTU T, Nihtinen A, Niittyvuopio R, Juvonen E, et al
    A randomized study of cyclosporine and methotrexate with or without methylprednisolone for the prevention of graft-versus-host disease: Improved long-term survival with triple prophylaxis.
    Cancer. 2017 Nov 7. doi: 10.1002/cncr.31100.
    PubMed     Abstract available

    September 2017
  32. SCHEICH S, Lindner S, Koenig R, Reinheimer C, et al
    Clinical impact of colonization with multidrug-resistant organisms on outcome after allogeneic stem cell transplantation in patients with acute myeloid leukemia.
    Cancer. 2017 Sep 28. doi: 10.1002/cncr.31045.
    PubMed     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Stem Cell Research is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.